Cite

HARVARD Citation

    Schuetze, S. et al. (2017). Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Cancer. 123 (1), pp. 90-97. [Online]. 
  
Back to record